Royal Bank Of Canada Editas Medicine, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 26,928 shares of EDIT stock, worth $35,275. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,928

Previous 27,802 3.14%

Holding current value

$35,275

Previous $129,000 29.46%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.39 - $5.96 $2,962 - $5,209	-874 Reduced 3.14%	26,928 $91,000
Q2 2024 Aug 14, 2024	BUY	$4.67 - $7.28 $30,691 - $47,844	6,572 Added 30.96%	27,802 $129,000
Q1 2024 Nov 05, 2024	SELL	$7.03 - $11.07 $46,201 - $72,752	-6,572 Reduced 23.64%	21,230 $157,000
Q1 2024 May 15, 2024	SELL	$7.03 - $11.07 $148,480 - $233,809	-21,121 Reduced 49.87%	21,230 $157,000
Q4 2023 Feb 14, 2024	BUY	$6.25 - $11.11 $806 - $1,433	129 Added 0.31%	42,351 $429,000
Q3 2023 Nov 14, 2023	BUY	$6.92 - $9.31 $88,880 - $119,577	12,844 Added 43.72%	42,222 $329,000
Q2 2023 Aug 14, 2023	BUY	$6.36 - $11.47 $45,715 - $82,446	7,188 Added 32.39%	29,378 $241,000
Q1 2023 May 15, 2023	SELL	$7.03 - $11.53 $360,392 - $591,085	-51,265 Reduced 69.79%	22,190 $160,000
Q4 2022 Feb 14, 2023	SELL	$8.32 - $13.21 $24,377 - $38,705	-2,930 Reduced 3.84%	73,455 $651,000
Q3 2022 Nov 14, 2022	BUY	$12.16 - $19.42 $26,192 - $41,830	2,154 Added 2.9%	76,385 $935,000
Q2 2022 Aug 15, 2022	SELL	$9.99 - $21.35 $26,183 - $55,958	-2,621 Reduced 3.41%	74,231 $879,000
Q1 2022 May 16, 2022	BUY	$14.08 - $27.63 $220,830 - $433,348	15,684 Added 25.64%	76,852 $1.46 Million
Q4 2021 Feb 14, 2022	BUY	$26.55 - $40.57 $250,472 - $382,737	9,434 Added 18.24%	61,168 $1.63 Million
Q3 2021 Nov 15, 2021	SELL	$39.27 - $72.94 $423,762 - $787,095	-10,791 Reduced 17.26%	51,734 $2.13 Million
Q2 2021 Aug 16, 2021	BUY	$31.29 - $56.64 $1.96 Million - $3.54 Million	62,525 New	62,525 $3.54 Million

Others Institutions Holding EDIT

# of Institutions

248

Shares Held

57M

Call Options Held

410K

Put Options Held

394K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Editas Medicine, Inc. Transaction History